Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
& Willing, B
Disclaimer: We offer a compounded GLP-1 Formulation, which is not FDA-approved in any manner or clinically proven to provide any benefits
Animal Model:Neonatal Sprague-Dawley rats (male, 18-22g, postnatal day 7), hypoxic-ischemic brain damage (HIBD) model [2] Dosage:100 mg/kg Administration:Intraperitoneal injection, once daily, for 14 consecutive days starting 24 hours after HIBD induction Result:Brain injury: Reduced infarct volume by 40% compared to the HIBD control group as measured by triphenyltetrazolium chloride (TTC) staining
Ali and his cohort say that they have observed the long-term effects of KTP after about 11 years of experimental animal and patient studiespublished in places like the British Journal of Ophthalmology , the Journal of Cataract and Refractive Surgery , and Cornea but were still about a decade short of the very long-term benchmark
US$ 25.98
US$ 24.74
US$ 22.28
US$ 27.60
